Scientists map bacteria in lung cancer patients to pave way for new treatments
NCT ID NCT03068663
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at the bacteria living in the gut, lungs, and airways of 40 people with non-small cell lung cancer. Half receive surgery only, and half get chemotherapy before surgery. Researchers collect samples like blood, saliva, stool, and lung tissue to see how these bacteria change. The goal is to understand the bacteria better so future studies can test if probiotics help make cancer treatment work better or cause fewer side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could lay the groundwork for future treatments that use probiotics or prebiotics to improve cancer therapy tolerance and effectiveness.
What could go wrong
This is a small, early exploratory study with only 40 participants, so results may not apply to all lung cancer patients. It does not test any treatment directly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL-CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Jean Perrin
Clermont-Ferrand, Puy de dôme, 63003, France